What is the average price target for MEDICLIN AG (MED.DE) stock?
5 analysts have analysed MED.DE and the average price target is 6.32 EUR. This implies a price increase of 83.84% is expected in the next year compared to the current price of 3.44.
MEDICLIN AG (MED.DE) Forecast, Price Target & Analyst Ratings
FRA:MED • DE0006595101
Current stock price
3.44 EUR
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICLIN AG (MED.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€6.32
Upside
+ 83.84%
From current price of €3.44 to mean target of €6.32, Based on 5 analyst forecasts
Low
€5.15
Median
€6.32
High
€7.67
Price Target Revisions
1 Month
7.83%
3 Months
7.83%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for MED.DE. The average price target is 6.32 EUR. This implies a price increase of 83.84% is expected in the next year compared to the current price of 3.44.
The average price target has been revised upward by 7.83% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
MED.DE was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MED.DE.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed MED.DE. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 766.746M 6.15% | 765.076M -0.22% | 804.316M 5.13% | 828.14M 2.96% | 849.04M 2.52% | 870.53M 2.53% | |
| EBITDA YoY % growth | 104.727M 15.18% | 110.369M 5.39% | 121.684M 10.25% | 113.43M -6.78% | 111.57M -1.64% | N/A | |
| EBIT YoY % growth | 18.722M -4.09% | 60.087M 220.95% | 61.462M 2.29% | 61.609M 0.24% | 60.287M -2.15% | N/A | |
| Operating Margin | 2.44% | 7.85% | 7.64% | 7.44% | 7.10% | N/A | |
| EPS YoY % growth | N/A -175.76% | N/A 428.00% | N/A 78.05% | 0.75 1.37% | 0.76 1.35% | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.28%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MEDICLIN AG / MED.DE Forecast FAQ
Can you provide the upcoming earnings date for MEDICLIN AG?
MEDICLIN AG (MED.DE) will report earnings on 2026-05-04.
What is the number of analysts for MED stock?
The number of analysts covering MEDICLIN AG (MED.DE) is 5.